HOrsey told ya'll- FEEd BAG IS On!
Shorts haven't decided yet, escape with a small squeeze, or putting balls to table and trying to ride this down with publicity and pressure working against. Hence the silence on here.
Monday will tell.
Can't wait to hear all the lame bashing!!!!
GIDDEEE UP CHUCK!
Boxer short boys have had been posting on our long share owners message board they worked very hard and posting for hedge fund one hundred dollars a day seven days a week 24 hours a day .what a hard working boys . English man need you boys posting for him to teaching you boys in school time . Professor . Dogman going to paid or play all boxer shorts two hundred dollars to attend school ) o ( plus tips 25 percents . Strong sell ????? Go for it .
Sentiment: Strong Sell
sweetpickings wrote: "The earnings that you saw for next quarter are only ebidta earnings." Hmmm, you might be right about EBITDA. Yahoo should have a footnote saying where the data came from and if it is adjusted EPS or regular net income EPS.
Anyway, Pernix should of started paying off part of the principle on the debt in the first quarter. So maybe the interest might decline slightly. That is if company did not take on more debt.
All boxer short boys . You boys need to going back to .english man school on this coming monday . English man teaching you how to learn at their school . Gl and enjoin at . English school ) 0 (
Starting just before Bill Clinton was elected Governor of Arkansas, Hillary Rodham Clinton made about $100,000 in one year in the commodities market with the help and advice of a friend who was the top lawyer for one of the state's most powerful and heavily regulated companies.
The investments, made in a commodities trading account that was opened three weeks before Mr. Clinton was elected Governor in 1978, substantially altered the finances of the Clintons. At the time, Mr. Clinton was Attorney General. He and his wife were rising stars in Little Rock whose salaries were modest by the standards of their peers.
The proceeds helped them to buy a home, to invest in securities and real estate and eventually to provide a nest egg for their young daughter, according to the couple's associates and a review of the family's financial records. Tyson's Fortunes
But the trades, which came to light during a two-month examination of the Clintons' finances by The New York Times, also left them in the position of having relied significantly on the help of one of the state's premier powerbrokers, James B. Blair, a Clinton confidant who at the time was the primary outside lawyer for Tyson Foods Inc., of Springdale, Ark., the nation's biggest poultry company.
During Mr. Clinton's tenure in Arkansas, Tyson benefited from a variety of state actions, including $9 million in government loans, the placement of company executives on important state boards and favorable decisions on environmental issues. Even today, critics in Congress and elsewhere have complained that the Clinton Administration is too close to Tyson and the poultry industry it dominates, sparing it from some of the tougher Federal inspection guidelines enacted against the meat industry. Her Money, Her Risk
Pernix Therapeutics Holdings, Inc. is a specialty pharmaceutical company. The Company focuses on identifying, developing and commercializing differentiated products that address unmet medical needs. It focuses on underserved therapeutic areas, such as central nervous system (CNS), including neurology and psychiatry, as well as other specialty therapeutic areas. Its products include Treximet, indicated for ACUTE MIGRAINE; Zohydro ER with BeadTek, an extended-release opioid agonist indicated for the management of PAIN SEVERE; Silenor for the treatment of INSOMNIA characterized by difficulty with SLEEP MAINTENANCE, and Khedezla for major depressive disorder. It promotes selected non-core branded products, such as its COUGH AND COLD PRODUCTS, through co-promotion arrangements with third-party sales organizations, and distributes its generic products through its subsidiaries, Macoven Pharmaceuticals, LLC (Macoven) and Cypress Pharmaceuticals, Inc.
Teva Pharmaceutical Industries Limited is a global pharmaceutical company. The Company is engaged in developing, producing and marketing generic medicines and a portfolio of specialty medicines. The Company operates through two segments: Generic medicines and Specialty medicines. It has a global portfolio of approximately 1,000 molecules. Its central nervous system (CNS) portfolio includes Copaxone for the treatment of multiple sclerosis, Azilect for the treatment of the symptoms of Parkinson's disease and Nuvigil for the treatment of SLEEP DISORDERS, as well as several therapies for the treatment of PAIN CARE. Its main RESPIRATORY MEDICINES include ProAir hydrofluoroalkane, QVAR and Duoresp Spiromax. Its oncology portfolio includes Treanda, Trisenox, Granix Synribo in the United States and Lonquex, Tevagrastim/Ratiograstim, Myocet, Trisenox and Eporatio outside the United States. Its women's health portfolio includes ParaGard, Plan B One-Step OTC/Rx (levonorgestrel) and Zoely.
The earnings that you saw for next quarter are only ebidta earnings. It is easy to show a profit when you do not include some expenses like the nearly $9.5 million a quarter in interest. That is why my next sentence talks about negative cash flow. 90 days ago they were supposed to make 14 cents next quarter and that has been lowered to .04 ebidta now. If they meet the average analyst yearly numbers for this year and next, they will be CASH FLOW negative both years.
Congrats to the day traders!
Congrats to longs. If you are out, would you all consider it too late to enter for a swing? may hold longer. Im 22 years old and lost my #$%$ already and down 50%...this looks promising at least for a day or two, but would you all say it is honestly still okay to buy monday morning? if yes, 9:30? or wait for a dip soon after then buy? thanks in advance.
A 13G filing showing 5% ownership by a "celebrity" investor is it's own catalyst for higher prices. Since he is underwater with his first 1,000,000 share purchase of PTX in 2015, averaging down significantly with enough shares to submit a highly publicized SEC filing could be a good strategy to create excitement and a higher sp. Cynical maybe and just a guess on my part, but the AH activity as well as comments on this message board and others about a new position by an elite investor is some confirmation of an intent which would have no bearing on Cohen's current analysis of PTX.
For the quarter ending March 2016, analysts guestimate negative earnings of -$0.18 to $0.00 with revenue of $41.5 to $46.8 million. But for June 2016 quarter, analysts have been guestimating positive earnings of $0.02 to $0.07 with revenue of $48 to $51 million. Of course, the analysts will probably adjust their guesses after seeing the 1st quarter financial report being released next week on May 5th.
sweetpickings wrote Apr 23, 2016 12:13 PM: "What earnings?...Analysts predict them to be cash flow negative the next two years." I guess you were mistaken and posting a comment based on memory. Analysts are guestimating a positive 2016 year of $0.04 to $0.12. But one should put not put much weight on analyst's opinion.
In 1978 and 1979, lawyer and First Lady of Arkansas Hillary Rodham engaged in a series of trades of cattle futures contracts. Her initial $1,000 investment had generated nearly $100,000 when she stopped trading after ten months. In 1994, after Hillary Rodham Clinton had become First Lady of the United States, the trading became the subject of considerable controversy regarding the likelihood of such a spectacular rate of return, possible conflict of interest, and allegations of disguised bribery, allegations that Clinton strongly denied. There were no official investigations of the trading and Clinton was never charged with any wrongdoing.
Charles Schwab had a ranking of 1 out of 100 and a 2 when the stock fell to $1.00. An 'A' or a Strong Buy. Now they have an 'NR' Not Ranked, because a stock under $1 is no longer covered. This brokerage is very conservative and so their practically unheard of recommendation and the stock plummet are in opposition and someone's assessment appears to look wrong. I figure that the stock was shorted, under pressure and driven down beyond a fair stock price, no matter the company issues or debt load. The After Hours revelation being a large block position by an investor in good faith is only a catalyst creating a kick start in an upswing to a fair stock price that is yet to be determined.
Point72 has held 1,050,000 shares for some time. Not sure when in 2015 they first invested but it was before 12/31/15. They recently added 2,700,000 shares to move them over 5%, the reason for the13G filing. Was this because of a catalyst they believe is coming soon or simply to average down......or both? We'll know soon enough. (Why do some of these articles refer to Pernix as being in the "finance sector"?)
The New Steve Cohen’s Point72 Asset Management Holding in Pernix Therapeutics Holdings, Inc
Point72 Asset Management filed with the SEC SC 13G form for Pernix Therapeutics Holdings, Inc. The form can be accessed here: 000089914016001387. As reported in Steve Cohen’s Point72 Asset Management’s form, the filler as of late owns 5.8% or 3,724,544 shares of the Finance–company.
Pernix Therapeutics Holdings, Inc stake is a new one for the for the hedge fund and it was filed because of activity on April 28, 2016. We feel this shows Steve Cohen’s Point72 Asset Management’s positive view for the stock.
The hedge fund is active investor in the Finance sector. In the manager’s last 13-F, we saw 25% of Steve Cohen’s Point72 Asset Management’s US equities portfolio is in this sector.